1. Home
  2. GHRS vs PDFS Comparison

GHRS vs PDFS Comparison

Compare GHRS & PDFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • PDFS
  • Stock Information
  • Founded
  • GHRS 2018
  • PDFS 1992
  • Country
  • GHRS Ireland
  • PDFS United States
  • Employees
  • GHRS N/A
  • PDFS N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • PDFS EDP Services
  • Sector
  • GHRS Health Care
  • PDFS Technology
  • Exchange
  • GHRS Nasdaq
  • PDFS Nasdaq
  • Market Cap
  • GHRS 583.1M
  • PDFS 668.1M
  • IPO Year
  • GHRS 2021
  • PDFS N/A
  • Fundamental
  • Price
  • GHRS $12.03
  • PDFS $17.70
  • Analyst Decision
  • GHRS Strong Buy
  • PDFS Strong Buy
  • Analyst Count
  • GHRS 8
  • PDFS 3
  • Target Price
  • GHRS $30.63
  • PDFS $33.33
  • AVG Volume (30 Days)
  • GHRS 149.3K
  • PDFS 224.9K
  • Earning Date
  • GHRS 05-08-2025
  • PDFS 05-08-2025
  • Dividend Yield
  • GHRS N/A
  • PDFS N/A
  • EPS Growth
  • GHRS N/A
  • PDFS N/A
  • EPS
  • GHRS N/A
  • PDFS 0.03
  • Revenue
  • GHRS N/A
  • PDFS $185,933,000.00
  • Revenue This Year
  • GHRS N/A
  • PDFS $23.39
  • Revenue Next Year
  • GHRS N/A
  • PDFS $18.37
  • P/E Ratio
  • GHRS N/A
  • PDFS $488.55
  • Revenue Growth
  • GHRS N/A
  • PDFS 11.75
  • 52 Week Low
  • GHRS $6.00
  • PDFS $15.91
  • 52 Week High
  • GHRS $20.50
  • PDFS $39.70
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 58.82
  • PDFS 40.12
  • Support Level
  • GHRS $10.66
  • PDFS $18.05
  • Resistance Level
  • GHRS $13.00
  • PDFS $19.14
  • Average True Range (ATR)
  • GHRS 0.96
  • PDFS 0.71
  • MACD
  • GHRS 0.12
  • PDFS -0.15
  • Stochastic Oscillator
  • GHRS 67.84
  • PDFS 10.29

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About PDFS PDF Solutions Inc.

PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.

Share on Social Networks: